Immunoglobulin-based therapies ... and their receptors Patients with rheumatic diseases could benefit from IVIg therapy since it behaves as a single drug with multiple targets The mechanisms ...
Total IgG levels were determined in serum samples pretreatment and again 2 weeks after treatment. Some patients also had IgG levels measured at 4 weeks (91 patients), 3 months (86 patients), and 6 ...
today announced the launch of its free AI-powered appeals platform designed to help children with PANS/PANDAS overcome insurance denials and access critical intravenous immunoglobulin (IVIG ...
Nov. 21, 2024 (GLOBE NEWSWIRE) -- Claimable, a pioneering healthcare technology company, today announced the launch of its free AI-powered appeals platform designed to help children with PANS/PANDAS ...
a leading provider of specialty infusion therapy, announced today that it has been selected by GC Biopharma as a limited distribution partner for ALYGLO™, an FDA-approved immunoglobulin ...